DexCom Incorporates Significant Revenue and Earnings Growth in Q2 2024
Monday, 29 July 2024, 14:04
![AlphaStreet](https://store.livarava.com/ad4944d1-4dba-11ef-a912-01b895e04db0.jpg)
DexCom Q2 2024 Financial Results
Healthcare company DexCom, Inc. (NASDAQ: DXCM) has announced its financial results for the second quarter of 2024, showcasing significant progress.
Key Financial Metrics
- Revenue increased by 15% year-over-year.
- Reported revenue reached $1 billion.
- U.S. revenue experienced a growth of 19%.
- International revenue grew 7%.
Future Guidance
DexCom is anticipated to maintain its positive trajectory, issuing guidance for continued growth in fiscal 2024.
This article was prepared using information from open sources in accordance with the principles of Ethical Policy. The editorial team is not responsible for absolute accuracy, as it relies on data from the sources referenced.